Drug companies are struggling to keep up with the rising demand for new medicines because of the competitive, timely and costly nature of the drug discovery pipeline. In order to deliver new medicines to the people who need them the most, researchers and drug companies need to work together to speed up the process of drug discovery.
By opening up access to newly discovered protein structures and drug targets, Oxford researchers are doing just that.